Assignee
ADAGENE INC
KY·12 granted patents·7 pending applications·25 citations·filing 2013–2025
Top patents by PatentIndex Score
19 records- 0192US11242395B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2018·Granted Feb 8, 2022·13 cites·29 claims
- 0288US11359016B2Anti-CTLA4 antibodies and methods of making and using the sameADAGENE INC·Filed 2019·Granted Jun 14, 2022·5 cites·40 claims
- 0386US11859003B2Method for treating cancer using anti-CD137 antibodyADAGENE INC·Filed 2018·Granted Jan 2, 2024·3 cites·18 claims
- 0485US2026071204A1Integrated system for library construction, affinity binder screening and expression thereofADAGENE INC·Filed 2025·Application pending·0 cites
- 0581US11952681B2Masked activatable CD137 antibodiesADAGENE INC·Filed 2019·Granted Apr 9, 2024·1 cites·43 claims
- 0680US11585014B2Dynamic human antibody light chain librariesADAGENE INC·Filed 2017·Granted Feb 21, 2023·2 cites·23 claims
- 0775US11578426B2Dynamic human heavy chain antibody librariesADAGENE INC·Filed 2017·Granted Feb 14, 2023·1 cites·34 claims
- 0875US2024141046A1Anti-ctla4 antibodies and methods of making and using the sameADAGENE INC·Filed 2023·Application pending·0 cites
- 0974US12503693B2Integrated system for library construction, affinity binder screening and expression thereofADAGENE INC·Filed 2021·Granted Dec 23, 2025·0 cites·6 claims
- 1073US2024150749A1Activatable antibodies and methods of making and using thereofADAGENE INC·Filed 2023·Application pending·0 cites
- 1171US12378319B2Anti-CD137 molecules and use thereofADAGENE INC·Filed 2021·Granted Aug 5, 2025·0 cites·13 claims
- 1270US12385162B2Dynamic human heavy chain antibody librariesADAGENE INC·Filed 2023·Granted Aug 12, 2025·0 cites·32 claims
- 1369US2023287597A1Dynamic human antibody light chain librariesADAGENE INC·Filed 2023·Application pending·0 cites
- 1466US2019241886A1Precision/context-dependent activatable antibodies, and methods of making and using the sameADAGENE INC·Filed 2019·Application pending·0 cites
- 1564US11692036B2Anti-CTLA4 antibodies and methods of making and using the sameADAGENE INC·Filed 2019·Granted Jul 4, 2023·0 cites·28 claims
- 1656US2024209092A1Combination therapies for treating cancerADAGENE INC·Filed 2022·Application pending·0 cites
- 1756US2016145604A1An Integrated System for Library Construction, Affinity Binder Screening and Expression ThereofADAGENE INC·Filed 2013·Application pending·0 cites
- 1855US12054548B2Anti-PD-L1 antibodies and use thereofADAGENE INC·Filed 2019·Granted Aug 6, 2024·0 cites·11 claims
- 1948US11485977B2Methods and systems for autoinduction of protein expressionADAGENE INC·Filed 2014·Granted Nov 1, 2022·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →